<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03311360</url>
  </required_header>
  <id_info>
    <org_study_id>CSIR01</org_study_id>
    <nct_id>NCT03311360</nct_id>
  </id_info>
  <brief_title>Drug Coated Balloon Versus Stenting in Patients With Symptomatic Vertebral Artery Stenosis：an Observational Clinical Study</brief_title>
  <official_title>Chinese Society of Interventional Radiology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Society of Interventional Radiology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Society of Interventional Radiology</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are two arms in our trial, DCB group, BMS group.The investigators are going to&#xD;
      investigate the safety and efficacy of all groups at 6 months and 12 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">October 1, 2020</completion_date>
  <primary_completion_date type="Actual">February 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of vascular death,non-fatal myocardial and non-fatal stroke in 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>vascular death,non-fatal myocardial and non-fatal stroke diagnosed by specialist physician</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>lumen loss at 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>lumen loss measured by doppler untrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lumen loss at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>lumen loss measured by doppler untrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>restenosis at 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>restenosis was assessed by doppler untrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>restenosis at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>restenosis was assessed by doppler untrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>traget lesion revascularizition at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>traget lesion revascularizition including envascular intervention and Surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of safety events including vascular death,non-fatal myocardial infarction, or non-fatal stroke in 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>safety events including vascular death,non-fatal myocardial infarction, or non-fatal stroke diagnosed by investigators within 30 days after start of the treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stent fracture rate at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>stent fracture was assessed by DSA</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">95</enrollment>
  <condition>Vertebral Artery Origin Stenosis</condition>
  <arm_group>
    <arm_group_label>drug-coated balloon</arm_group_label>
    <description>patients with vertebral artery origin stenosis treated with drug-coated balloons</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bare metal stent</arm_group_label>
    <description>patients with vertebral artery origin stenosis treated with bare metal stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>drug-coated balloon</intervention_name>
    <description>Orchid and Dahlia DCB</description>
    <arm_group_label>drug-coated balloon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bare metal stent</intervention_name>
    <description>any type of bare metal stent</description>
    <arm_group_label>bare metal stent</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients meet all of the inclusion criteria and none of the excusion criteria&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. aged between 18 and 80 years old;&#xD;
&#xD;
          2. TIA or non-disabling ischaemic stroke of the posterior circulation;&#xD;
&#xD;
          3. symptoms occurred in the 14 days and could not be relieved after 2 months of regular&#xD;
             medication&#xD;
&#xD;
          4. stenosis of the vertebral artery of 50% or greater, diagnosed by both CT angiography&#xD;
             or angiography;&#xD;
&#xD;
          5. NIHSS≤ 6;&#xD;
&#xD;
          6. score on the modified Rankin scale ≤ 3.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Active bleeding or coagulation disorders or severe renal/liver impairment&#xD;
&#xD;
          2. allergy to iodinated contrast agent or related medicines;&#xD;
&#xD;
          3. acute stroke in 3 weeks&#xD;
&#xD;
          4. more than 1 stenosis at the target vessel or Distal vascular dysplasia (diameter≤3mm)&#xD;
&#xD;
          5. a potential cause of stenosis other than atherosclerosis&#xD;
&#xD;
          6. Severe stenosis was found in the anterior circulation artery(&gt;70%)&#xD;
&#xD;
          7. intracranial hemorrhage or hemorrhagic stroke, intracranial tumor, cerebral&#xD;
             arteriovenous malformation, or intracranial aneurysm in 30 days;&#xD;
&#xD;
          8. ISR patients;&#xD;
&#xD;
          9. Severe calcification lesion；&#xD;
&#xD;
         10. obvious thrombosis in vessel;&#xD;
&#xD;
         11. pregnancy;&#xD;
&#xD;
         12. a potential cause of TIA or minor stroke other than stenosis in a vertebral artery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Beijing Anzhen hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The rockets army general hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital of Dalian medical university</name>
      <address>
        <city>Dalian</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital of Harbin medical university</name>
      <address>
        <city>Harbin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The first hospital of Jilin university</name>
      <address>
        <city>Jilin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shengjing Hosptal of china medical university</name>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henan provincial peoples hospital</name>
      <address>
        <city>Zhengzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The first hospital of zhengzhou university</name>
      <address>
        <city>Zhengzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zhengzhou center hospital</name>
      <address>
        <city>Zhengzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>October 9, 2017</study_first_submitted>
  <study_first_submitted_qc>October 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2017</study_first_posted>
  <last_update_submitted>July 31, 2021</last_update_submitted>
  <last_update_submitted_qc>July 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vertebral artery origin stenosis</keyword>
  <keyword>drug-coated balloon</keyword>
  <keyword>stenting</keyword>
  <keyword>medical treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

